Dose-limiting myelosuppression associated with high-dose cisplatin (200 mg/m2) in hypertonic saline. [electronic resource]
- Cancer treatment reports Jun 1986
- 820-1 p. digital
Publication Type: Letter
0361-5960
Cisplatin--administration & dosage Drug Administration Schedule Drug Evaluation Hematologic Diseases--chemically induced Humans Lung Neoplasms--drug therapy